Z7J-32411-78233
4 vaccinations
7 coded responses
50 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 079 / NJ
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Pfizer-BioNTech
-
2020-12-30
Survey response — day 0, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Mild muscle discomfort at injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-31
Survey response — days 1–6 daily, dose 1MedDRA: Musculoskeletal discomfort — Feeling: Good · Site: SwellingFree text: Mild discomfort when abducting shoulder.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-13
-
2021-01-19
Dose 2 — Pfizer-BioNTech
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-04-20
-
2021-07-20
Survey response — 6 months, dose 2MedDRA: Glucose tolerance impaired, Glycosylated haemoglobin increased, Office visit — Feeling: GoodFree text: Elevated hba1c of 5.9 (prediabetes) at last physical - June 2021MedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Dose 3 — Pfizer-BioNTech
-
2021-12-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-13
-
2021-12-14
Survey response — days 1–6 daily, dose 3MedDRA: Arthralgia, Muscle spasms — Feeling: GoodFree text: Leg/foot cramps last night; hip discomfort during ambulating.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-15
- 2021-12-16
- 2021-12-17
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-01-14
- 2022-01-21
- 2022-03-11
- 2022-06-10
-
2022-07-01
Dose 4 — Pfizer-BioNTech
-
2022-07-03
Survey response — days 1–6 daily, dose 4MedDRA: Chills, Headache, Injection site pain — Feeling: Good · Site: PainFree text: I had pain at the injection site, chills and a headache exactly 12 hours post injection that lasted 36 hours. Now I am feeling fine.MedDRA releases: 2024-11 · check-in free text available
- 2022-07-04
- 2022-07-05
- 2022-07-06
- 2022-07-07
- 2022-07-08
- 2022-07-15
- 2022-07-22
-
2022-07-29
Survey response — day 28, dose 4MedDRA: Eye haemorrhage — Feeling: GoodFree text: Burst blood vessel in right eye. Cleared in about 4 days.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-05
Survey response — day 35, dose 4MedDRA: Dizziness — Feeling: GoodFree text: Occasionally dizzy, especially when scrolling on cell phone. Could be allergy/sinus issue.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-12
- 2022-09-30
- 2022-12-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech | |
| 3 | 2021-12-10 | Pfizer-BioNTech | No |
| 4 | 2022-07-01 | Pfizer-BioNTech | No |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Mild muscle discomfort at injection site.
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Mild discomfort when abducting shoulder.
Release 9 — 6 months, dose 2
Symptoms: Elevated hba1c of 5.9 (prediabetes) at last physical - June 2021
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Leg/foot cramps last night; hip discomfort during ambulating.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): I had pain at the injection site, chills and a headache exactly 12 hours post injection that lasted 36 hours. Now I am feeling fine.
Release 12 — day 28, dose 4
Symptoms: Burst blood vessel in right eye. Cleared in about 4 days.
Release 12 — day 35, dose 4
Symptoms: Occasionally dizzy, especially when scrolling on cell phone. Could be allergy/sinus issue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Eye haemorrhage | · | · | ✓ |
| SD | Glucose tolerance impaired | · | · | ✓ |
| SD | Glycosylated haemoglobin increased | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SRO | Arthralgia | · | · | ✓ |
| SRO | Chills | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Injection site discomfort | ○ | ○ | ○ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Muscle spasms | · | · | ✓ |
| SRO | Musculoskeletal discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release